NSE
Mangalam Drugs And Organics LimitedMANGALAM
Mangalam Drugs And Organics Limited is an Indian pharmaceutical company focused on manufacturing and distribution of drugs and organic products.
| Key products | Pharmaceuticals, Organic Products |
|---|---|
| Geography | India |
| Competitors | Dr Reddy's Laboratories, Cadila Healthcare |
AI-generated overview — verify before relying on it.
Net institutional flow
−₹0 Cr
Institutional buyers
2 in / 3 out
High-impact filings
1 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹4.8 Cr | 91 | — | — | — | — |
| 2 | MANGALAMThis | — | — | 1 | — | — | — |
| 3 | MOBIKWIK | +₹0 Cr | 12 | — | — | — | — |
| 4 | QUADFUTURE | +₹0 Cr | 34 | — | — | — | — |
| 5 | IRMENERGY | — | — | — | — | — | — |
| 6 | MTNL | — | — | — | — | — | — |
| 7 | GATECH | — | — | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-17FilingMangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/ArrestRisk
- 2026-06-17FilingMangalam Drugs And Organics Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) Shareholding Disclosure
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 7
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF →
No bulk/block deals for MANGALAM in this window.
News & chatter on MANGALAM
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.